-- As dengue cases continue to rise in Malaysia, the importance of timely medical attention and appropriate care has become increasingly evident. As of Epidemiological Week 35 in 2026, 65,979 dengue cases and 62 deaths had been reported nationwide, representing a 66% increase in cases compared to the same period last year.
While some dengue patients require hospitalisation, others may be medically assessed as suitable for recovery and monitoring at home. However, recovering at home does not mean the illness should be taken lightly.
Recovery requires continued vigilance
A common misconception is that a subsiding fever means a patient is recovering well. In reality, patients should continue monitoring their condition closely even after their temperature returns to normal.
Patients are advised to follow their doctor's recommendations, attend scheduled follow-up appointments or blood tests, and remain alert to warning signs such as severe abdominal pain, persistent vomiting, bleeding, difficulty breathing, or a sudden deterioration in their overall condition. If symptoms worsen, medical attention should be sought immediately.
Patients should also avoid self-medicating and consult their doctor or pharmacist before taking any medication, particularly aspirin and certain non-steroidal anti-inflammatory drugs (NSAIDs), which may increase the risk of bleeding.
Professional support from the comfort of home
For eligible Allianz Life Insurance Malaysia Berhad (Allianz Life) customers, Allianz Care@Home provides professional medical support for dengue patients who are medically assessed as suitable for home management.*
Offered in partnership with Speedoc, the service includes home visits by doctors and nurses, monitoring, diagnostic tests, treatment, and access to a 24/7 medical assistance helpline throughout the recovery journey.
This enables eligible customers to receive professional medical attention while recovering in the familiarity and comfort of their own homes.
“At Allianz Life, we believe being there for our customers extends far beyond providing insurance coverage. It is about offering meaningful support when they need it most. Through Allianz Care@Home, we are making healthcare more accessible and convenient for eligible customers recovering from dengue by enabling professional medical care to be delivered in a familiar home environment,” Allianz Life Chief Executive Officer, Giulio Slavich said.
“This initiative reflects our commitment to understanding our customers' needs and continuously evolving our solutions to make their healthcare journey simpler, more seamless, and more reassuring. Ultimately, our goal is to help customers focus on their recovery and wellbeing,” he added.
Adapting care to patients' needs
As dengue can develop differently from one patient to another, home-based care should never be viewed as a replacement for hospitalisation when hospital treatment is medically necessary.
Should a patient's condition require a higher level of care, Allianz Care@Home can facilitate referrals to a medical service centre and assist with hospital admission. Ground ambulance services can also be arranged upon request, subject to availability.
Ultimately, whether dengue is managed at home or in hospital should always be determined through a medical assessment. What matters most is ensuring patients receive the right level of care at the right time.
Allianz Care@Home is available to eligible Allianz Life Individual Hospitalisation & Surgical customers and Group Corporate members under Allianz SME Choice Plus, subject to eligibility and applicable terms and conditions.
The service is currently available in Klang Valley, Penang, Ipoh, Negeri Sembilan, Melaka and Johor. Eligible customers may contact Speedoc's 24/7 medical assistance centre at +603 7890 0261 to request the service and undergo the necessary eligibility and medical assessment.
Visit Allianz Care@Home for more information.
*Terms and conditions apply
Allianz Life Chief Executive Officer, Giulio Slavich.
Download
Release ID: 89203891
Google
RSS